Clinical Study
Human Leukocyte Antigen Class I and II Alleles and Overall Survival in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Table 1
Demographic and clinical characteristics of DLBCL and FL patients from the NCI-SEER NHL study for which HLA typing was conducted.
| Characteristics | DLBCL | FL | (%) | (%) |
| Sex | | | āMale | 99 (55.3) | 89 (49.4) | āFemale | 80 (44.7) | 91 (50.6) | Age (years) | | | ā<60 | 93 (52.0) | 103 (57.2) | ā60+ | 86 (48.0) | 77 (42.8) | Race | | | āNon-Hispanic Caucasian | 165 (92.2) | 165 (91.7) | āOther | 14 (7.8) | 15 (8.3) | Study Center | | | āDetroit | 19 (10.6) | 16 (8.9) | āIowa | 67 (37.4) | 76 (42.2) | āLos Angeles | 29 (16.2) | 30 (16.7) | āSeattle | 64 (35.8) | 58 (32.2) | Education (years) | | | ā<12 | 16 (8.9) | 11 (6.1) | ā12ā15 | 118 (65.9) | 118 (65.6) | ā16+ | 45 (25.1) | 51 (28.3) | Stage | | | āLocal | 69 (38.6) | 44 (24.4) | āRegional | 39 (21.8) | 25 (13.9) | āDistant | 38 (38.0) | 101 (56.1) | āUnknown | 3 (1.7) | 10 (5.6) | Presence of B symptoms | | | āNo | 136 (76.0) | 154 (85.6) | āYes | 43 (24.0) | 26 (14.4) |
|
|